The PPARγ-SETD8 axis constitutes an epigenetic, p53-independent checkpoint on p21-mediated cellular senescence

Aging Cell. 2017 Aug;16(4):797-813. doi: 10.1111/acel.12607. Epub 2017 May 17.

Abstract

Cellular senescence is a permanent proliferative arrest triggered by genome instability or aberrant growth stresses, acting as a protective or even tumor-suppressive mechanism. While several key aspects of gene regulation have been known to program this cessation of cell growth, the involvement of the epigenetic regulation has just emerged but remains largely unresolved. Using a systems approach that is based on targeted gene profiling, we uncovered known and novel chromatin modifiers with putative link to the senescent state of the cells. Among these, we identified SETD8 as a new target as well as a key regulator of the cellular senescence signaling. Knockdown of SETD8 triggered senescence induction in proliferative culture, irrespectively of the p53 status of the cells; ectopic expression of this epigenetic writer alleviated the extent doxorubicin-induced cellular senescence. This repressive effect of SETD8 in senescence was mediated by directly maintaining the silencing mark H4K20me1 at the locus of the senescence switch gene p21. Further in support of this regulatory link, depletion of p21 reversed this SETD8-mediated cellular senescence. Additionally, we found that PPARγ acts upstream and regulates SETD8 expression in proliferating cells. Downregulation of PPARγ coincided with the senescence induction, while its activation inhibited the progression of this process. Viewed together, our findings delineated a new epigenetic pathway through which the PPARγ-SETD8 axis directly silences p21 expression and consequently impinges on its senescence-inducing function. This implies that SETD8 may be part of a cell proliferation checkpoint mechanism and has important implications in antitumor therapeutics.

Keywords: H4K20me1; SETD8/KMT5A; cellular senescence; epigenetic; p21; p53.

MeSH terms

  • Cell Cycle Checkpoints / drug effects
  • Cell Cycle Checkpoints / genetics
  • Cell Cycle Checkpoints / radiation effects
  • Cell Line, Tumor
  • Cellular Senescence / drug effects
  • Cellular Senescence / genetics*
  • Cellular Senescence / radiation effects
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics*
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • DNA Damage
  • Doxorubicin / pharmacology
  • Epigenesis, Genetic*
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fibroblasts / radiation effects
  • Histone-Lysine N-Methyltransferase / genetics*
  • Histone-Lysine N-Methyltransferase / metabolism
  • Histones / genetics
  • Histones / metabolism
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Lung / cytology
  • Lung / drug effects
  • Lung / metabolism
  • Lung / radiation effects
  • PPAR gamma / genetics*
  • PPAR gamma / metabolism
  • Primary Cell Culture
  • Signal Transduction
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • Ultraviolet Rays

Substances

  • Cyclin-Dependent Kinase Inhibitor p21
  • Histones
  • PPAR gamma
  • Tumor Suppressor Protein p53
  • Doxorubicin
  • Hydrogen Peroxide
  • Histone-Lysine N-Methyltransferase
  • KMT5A protein, human